Evofem Biosciences Inc Sustainability Reports
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes innovative products for women's sexual and reproductive health. Its core portfolio includes Phexxi, a hormone-free prescription contraceptive vaginal gel, and Solosec oral granules.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 5493007VAGG43TIEJW57
FIGI: BBG0026ZG469
1 reports from 2022 to 2022
